ChiCTR2500100227 版本V1.0 版本创建时间2025/04/07 08:33:46 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2500100227 

最近更新日期:

Date of Last Refreshed on:

2025-04-07 08:33:30 

注册时间:

Date of Registration:

2025-04-07 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

超声引导下甲状软骨平面阻滞在支撑喉镜下声带息肉切除术中的研究

Public title:

Study on Thyroid Cartilage Plane Block under Ultrasound Guidance in Supporting Laryngoscopy for Vocal Cord Polyp Resection

注册题目简写:

English Acronym:

研究课题的正式科学名称:

超声引导下甲状软骨平面阻滞在支撑喉镜下声带息肉切除术中的研究

Scientific title:

Study on Thyroid Cartilage Plane Block under Ultrasound Guidance in Supporting Laryngoscopy for Vocal Cord Polyp Resection

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

黄芳 

研究负责人:

黄芳 

Applicant:

Fang Huang 

Study leader:

Fang Huang 

申请注册联系人电话:

Applicant telephone:

+86 151 7616 5868

研究负责人电话:

Study leader's
telephone:

+86 151 7616 5868

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

18610416936@163.com

研究负责人电子邮件:

Study leader's E-mail:

18610416936@163.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

河北省石家庄市中国人民解放军联勤保障部队第九八〇医院麻醉科

研究负责人通讯地址:

河北省石家庄市中国人民解放军联勤保障部队第九八〇医院麻醉科

Applicant address:

The Department of Anesthesiology, No. 980 Hospital, Joint Logistics Support Force, People's Liberation Army, Shijiazhuang City, Hebei Province.

Study leader's address:

The Department of Anesthesiology, No. 980 Hospital, Joint Logistics Support Force, People's Liberation Army, Shijiazhuang City, Hebei Province.

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

中国人民解放军联勤保障部队第九八〇医院麻醉科

Applicant's institution:

The Department of Anesthesiology, No. 980 Hospital, Joint Logistics Support Force, People's Liberation Army.

研究负责人所在单位:

中国人民解放军联勤保障部队第九八〇医院麻醉科

Affiliation of the Leader:

The Department of Anesthesiology, No. 980 Hospital, Joint Logistics Support Force, People's Liberation Army.

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

(2025-KY-48)号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

中国人民解放军联勤保障部队第九八〇医院医学伦理委员会

Name of the ethic committee:

The Medical Ethics Committee of the 980th Hospital of the Joint Logistics Support Force of the People's Liberation Army

伦理委员会批准日期:

Date of approved by ethic committee:

2025-04-01 00:00:00

伦理委员会联系人:

朱铁年

Contact Name of the ethic committee:

Tienian Zhu

伦理委员会联系地址:

河北省石家庄市桥西区中山西路398号

Contact Address of the ethic committee:

Hebei Province, Shijiazhuang City, Qiaoxi District, Zhongshan West Road, No. 398

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 311 8156 8049

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

中国人民解放军联勤保障部队第九八〇医院麻醉科

Primary sponsor:

The Department of Anesthesiology, No. 980 Hospital, Joint Logistics Support Force, People's Liberation Army.

研究实施负责(组长)单位地址:

河北省石家庄市桥西区中山西路398号

Primary sponsor's address:

Hebei Province, Shijiazhuang City, Qiaoxi District, Zhongshan West Road, No. 398

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

河北省

市(区县):

石家庄市

Country:

China

Province:

Hebei

City:

Shijiazhuang

单位(医院):

中国人民解放军联勤保障部队第九八〇医院麻醉科

具体地址:

河北省石家庄市桥西区中山西路398号

Institution
hospital:

The Department of Anesthesiology, No. 980 Hospital, Joint Logistics Support Force, People's Liberation Army

Address:

Hebei Province, Shijiazhuang City, Qiaoxi District, Zhongshan West Road, No. 398

经费或物资来源:

北京市高层次卫生技术人才培养计划

Source(s) of funding:

Beijing High-level Health Technology Talent Cultivation Plan

研究疾病:

无  

Target disease:

None

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

治疗新技术临床试验 

Study phase:

New Treatment Measure Clinical Study

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

探讨超声引导下甲状软骨平面阻滞复合全麻对支撑喉镜下声带息肉切除患者术中应激反应、术后咽喉痛及早期恢复质量的影响,以期为临床支撑喉镜下声带息肉切除患者手术麻醉提供理论指导。  

Objectives of Study:

Explore the effects of ultrasound-guided thyroid cartilage plane block combined with general anesthesia on intraoperative stress response, postoperative throat pain, and early recovery quality in patients undergoing vocal cord polyp resection under suspension laryngoscopy, with the aim of providing theoretical guidance for clinical anesthesia during suspension laryngoscopy for vocal cord polyp resection in patients.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.择期拟在全麻下行支撑喉镜下喉病损切除术的患者; 2.年龄18-70岁,性别不限;ASA Ⅰ-Ⅱ级; 体重指数<30 kg/m^2; 3.患者知情同意;

Inclusion criteria

1. Patients scheduled for elective laryngeal lesion excision under suspension laryngoscopy with general anesthesia; 2. Age 18-70 years, regardless of gender; ASA grades I-II; Body Mass Index (BMI) < 30 kg/m^2; 3. Patient informed consent obtained;

排除标准:

1.术前合并认知功能障碍、精神疾病、凝血功能障碍者; 2.术前因存在可预料困难气道需要清醒气管插管者; 3.术前合并严重心血管系统和呼吸系统疾病者; 4.对研究药物过敏者; 5.在4 周内参与其他临床试验研究者; 6.拒绝进行该研究的患者。

Exclusion criteria:

1. Patients with preoperative cognitive dysfunction, mental illness, or coagulation disorders; 2. Patients requiring awake tracheal intubation due to the presence of predictable difficult airways before surgery; 3. Patients with severe cardiovascular and respiratory system diseases before surgery; 4. Patients allergic to the study medication; 5. Patients who have participated in other clinical trials within the past 4 weeks; 6. Patients who refuse to participate in this study.

研究实施时间:

Study execute time:

From 2025-04-07 00:00:00 To 2025-08-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2025-04-07 00:00:00 To 2025-08-31 00:00:00

干预措施:

Interventions:

组别:

对照组

样本量:

45

Group:

Control Group

Sample size:

干预措施:

全身麻醉

干预措施代码:

Intervention:

General anesthesia

Intervention code:

组别:

试验组组

样本量:

45

Group:

Test Group

Sample size:

干预措施:

全身麻醉+甲状软骨平面阻滞

干预措施代码:

Intervention:

General anesthesia + thyroid cartilage plane block

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

河北 

市(区县):

石家庄 

Country:

China

Province:

Hebei

City:

Shijiazhuang

单位(医院):

中国人民解放军联勤保障部队第九八〇医院麻醉科 

单位级别:

三甲 

Institution
hospital:

The Department of Anesthesiology, No. 980 Hospital, Joint Logistics Support Force, People's Liberation Army

Level of the institution:

Tertiary A

国家:

中国

省(直辖市):

北京 

市(区县):

 

Country:

China

Province:

Beijing

City:

单位(医院):

首都医科大学附属北京友谊医院 

单位级别:

三甲 

Institution
hospital:

Beijing Youyi Hospital,Capital Medical Unicersity

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

术后咽喉痛和声音嘶哑的发生率和严重程度

指标类型:

主要指标

Outcome:

Incidence and severity of postoperative sore throat and hoarseness

Type:

Primary indicator

测量时间点:

术后2小时

测量方法:

Measure time point of outcome:

2 hours post-operation

Measure method:

指标中文名:

术后咽喉痛和声音嘶哑的发生率和严重程度

指标类型:

次要指标

Outcome:

Incidence and severity of postoperative sore throat and hoarseness

Type:

Secondary indicator

测量时间点:

术后0.5小时、术后6小时、术后24小时

测量方法:

Measure time point of outcome:

Postoperative 0.5 hours, postoperative 6 hours, postoperative 24 hours

Measure method:

指标中文名:

不同时间点的血流动力学变化

指标类型:

次要指标

Outcome:

Hemodynamics at different time points

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

不同时间点的血糖水平

指标类型:

次要指标

Outcome:

Blood glucose levels at different time points

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后24小时恢复质量评分

指标类型:

次要指标

Outcome:

Postoperative 24-hour quality recovery score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后补充镇痛药剂量

指标类型:

次要指标

Outcome:

the rescue analgesic after surgery

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

术后满意度评分

指标类型:

次要指标

Outcome:

satisfaction score

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

手术总时间、气管拔除时间和术后并发症发生率

指标类型:

次要指标

Outcome:

Total operation time, time of tracheal extubation, and the incidence of postoperative complications

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

苏醒期间的咳嗽情况及其严重程度

指标类型:

次要指标

Outcome:

Coughing during the recovery period and its severity

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

插管期间喉镜检查时间,插管尝试次数、Cormack-Lehane分级

指标类型:

次要指标

Outcome:

During intubation, laryngoscopy examination time, number of intubation attempts, Cormack-Lehane grading

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

none

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

正在进行

Recruiting

年龄范围:

Participant age:

最小 Min age 18 years
最大 Max age 70 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

由不参与试验的一人使用计算机SPSS软件产生随机数字。

Randomization Procedure (please state who generates the random number sequence and by what method):

Generate random numbers using SPSS software by one person who did not participate in the experiment.

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

双盲

Blinding:

double blind

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

根据读者要求 请阅读网页注册指南中关于原始数据共享的内容

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Open according to readers' requirements

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

采用CRF病例记录表和EXCEL表进行数据采集和管理

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The data is collected by using CRF and Excel.

数据与安全监察委员会:

Data and Safety Monitoring Committee:

暂未确定/Not yet

注册人:

Name of Registration:

 2025-04-07 08:33:30